PATENT CLAIM ANALYSIS

Application Number: 16033645
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "210000"]

Abstract:
The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR120 G protein-coupled receptor modulators which may be used as medicaments.

Claim (Index 13):
The pharmaceutical composition according to  claim 12 , further comprising one or more other suitable therapeutic agents selected from: a dipeptidyl peptidase-IV inhibitor, a sodium-glucose transporter-2 inhibitor and a 11b-HSD-1 inhibitor.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.20513
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15509214', '14442642', '15308459', '14442670', '14442624']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7589687877566884
- 35 USC 102 Novelty (BERT): 0.5704715764699734
- Combined Prediction Score: 0.7401190666280169
- Mean Citation Score: 313.91508
- Max Citation Score: 447.84027
- Similarity Product: 394.3996823801672

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test